RCKT — Rocket Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSucker Stock

Annual balance sheet for Rocket Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	389	356	373	372	189
Prepaid Expenses
Total Current Assets	392	364	378	378	193
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	72.3	77.6	87.6	83.3	71.6
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	497	552	566	528	330
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	22.2	39.2	48.5	40.7	30.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	42.3	62.1	73.8	64.5	53.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	455	490	493	463	277
Total Liabilities & Shareholders' Equity	497	552	566	528	330
Total Common Shares Outstanding